Cargando…
Evidence for secondary thrombotic microangiopathy in COVID-19
The causes of coagulopathy associated with COVID-19 disease are poorly understood. We aimed to investigate the relationship between markers of endothelial activation, intravascular hemolysis, coagulation, and organ damage in COVID-19 patients and study their association with disease severity and mor...
Autores principales: | Sweeney, Joseph M., Barouqa, Mohammad, Krause, Gregory J., Gonzalez-Lugo, Jesus D., Rahman, Shafia, Gil, Morayma Reyes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587832/ https://www.ncbi.nlm.nih.gov/pubmed/33106812 http://dx.doi.org/10.1101/2020.10.20.20215608 |
Ejemplares similares
-
Low ADAMTS13 Activity Correlates with Increased Mortality in COVID-19 Patients
por: Sweeney, Joseph M., et al.
Publicado: (2021) -
Correlation of Coagulation Parameters With Clinical Outcomes During the Coronavirus-19 Surge in New York: Observational Cohort
por: Reyes Gil, Morayma, et al.
Publicado: (2021) -
Complement in Secondary Thrombotic Microangiopathy
por: Palma, Lilian Monteiro Pereira, et al.
Publicado: (2020) -
No Evidence for Classic Thrombotic Microangiopathy in COVID-19
por: Falter, Tanja, et al.
Publicado: (2021) -
Thrombotic microangiopathy secondary to recurrent prostate cancer
por: Newton, Joseph, et al.
Publicado: (2021)